Affymax, Inc. Stock Nasdaq
Equities
US00826A1097
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2012 | 94.37M 129M | Sales 2013 | 1.37M 1.87M | Capitalization | 29.24M 39.87M |
---|---|---|---|---|---|
Net income 2012 | -93M -127M | Net income 2013 | -14M -19.09M | EV / Sales 2012 | 6.75 x |
Net cash position 2012 | 69.14M 94.26M | Net cash position 2013 | 5.6M 7.63M | EV / Sales 2013 | 17.3 x |
P/E ratio 2012 |
-7.39
x | P/E ratio 2013 |
-2.03
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |